Dr. Thomas W. Axelrad, MD

Dr. Axelrad practices at Santa Rosa Orthopaedic Medical Group, Inc. in Santa Rosa, California.

Dr. Axelrad's NPI, 1326229204, was assigned on November 19, 2007. Dr. Axelrad graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2005. Dr. Axelrad's Massachusetts license number on file is 234337.

Dr. Axelrad's primary practice is Santa Rosa Orthopaedic Medical Group, Inc., at 1405 Montgomery Dr, Santa Rosa, CA 95405 in Sonoma County. The practice phone is (707) 546-1922.

Dr. Axelrad's primary practice is Santa Rosa Orthopaedic Medical Group, Inc. in Santa Rosa, California. Dr. Axelrad is also affiliated with Providence Santa Rosa Memorial Hospital. The medical group on file is Santa Rosa Orthopaedics. Dmand AI also links Dr. Axelrad to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Axelrad practices, 7 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Axelrad's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Axelrad is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Axelrad's licenses on file in 4 states: Massachusetts, California, Louisiana and Pennsylvania.

Dmand AI lists amputation, arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, bursitis, carpal tunnel syndrome, enthesopathy in foot or ankle and fluid in a joint among the conditions Dr. Axelrad treats.

CMS data shows 3,786 Medicare services from Dr. Axelrad across 35 procedure codes in 2024, for 497 Medicare patients. Medicare paid $257,756 for them.

CMS counts 497 Medicare patients who saw Dr. Axelrad in 2024. The largest group is 65 to 74, with 178 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Axelrad's median patient age at 67, with 53% women.

In 2024, Dr. Axelrad wrote 380 Medicare Part D claims for 130 patients. 97% of them were for generic drugs. CMS names the drug for 265 of them, across 9 drugs with 11 or more claims each, at $2,034 in total drug cost. In 2023, CMS named 214 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Axelrad for performance year 2024, reported as part of a group. Dr. Axelrad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 63 procedures of hip replacement by Dr. Axelrad, more than 91% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Upper limb (arm) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Axelrad in 2011. The most frequent topics are Radiography, Fracture Fixation, Internal and Fracture Healing. Dr. Axelrad has published most often in J Orthop Trauma. Dr. Axelrad's most frequent co-authors are Rachel M. Cymerman, MD, David L. Helfet, MD and Sanjeev Kakar, MD.

CMS Open Payments shows 407 general payments to Dr. Axelrad from 16 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 38% of the total. Globus Medical, Inc. paid the most, $89,439.

Dr. Axelrad graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2005.

Dr. Axelrad is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.